Delivery Order SPE2DR25D1103-SPE2DR26FD703
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $4,156.56 with a completion deadline of October 7, 2025. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit pack) on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,385.52, with an ultimate completion date of September 23, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units, valued at $4,156.56. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of October 9, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on June 6, 2025, with a completion date of June 30, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This order, valued at $16,626.24 with a firm fixed price structure, represents a non-competitive set-aside delivery against AmerisourceBergen's larger pharmaceutical supply contract. The order is scheduled for completion by October 2, 2025, and will be fulfilled from the company's Corporate Office facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open competition. The contract is scheduled for completion by November 18, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30-count units, with a contract ceiling value of $4,156.56 and an ultimate completion date of October 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania facility. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,156.56 and an ultimate completion date of October 20, 2025. The award was made on a competitive, non-set-aside basis to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a Delivery Order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FD703Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) under a firm fixed-price contract valued at $1,460.13. The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a non-set-aside competitive award. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial $999,999,999.00 value through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This prime IDV encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The current award for Orgovyx tablets reflects the company's ongoing role as a key pharmaceutical distributor within the federal medical supply chain, supporting military and veteran healthcare systems through the DLA's medical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/31/25 |